What is the ticker symbol for Kinnate Biopharma?

Kinnate Biopharma trades under the ticker KNTE on NASDAQ.

What sector does Kinnate Biopharma operate in?

Kinnate Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KNTE in a portfolio?

PortView shows KNTE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kinnate Biopharma (KNTE) Stock Analysis

NASDAQHealthcareBiotechnology

$2.65-0.38%

1-year price historyRange $1.07 – $6.84

52-week range$2.65

$1.04$7.19

What Kinnate Biopharma does

Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.

Key metrics

Market cap

$124.99M

P/E (TTM)

-0.95

EPS (TTM)

$-2.78

Beta

1.34

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.49

200-day avg

$2.25

52-week high

$7.19

52-week low

$1.04

CEO

Nima Farzan

ETFs linked to KNTE

Broad-market and Healthcare sector ETFs an investor holding Kinnate Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KNTE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KNTE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kinnate Biopharma?: Kinnate Biopharma trades under the ticker KNTE on NASDAQ.
Which exchange is KNTE listed on?: KNTE is listed on NASDAQ.
What sector does Kinnate Biopharma operate in?: Kinnate Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KNTE in a portfolio?: PortView shows KNTE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.